Home 禄 Business 禄 Manufacturing
Valeant seals US$8.7b eye health deal
Source: Agencies |
May 28, 2013, Tuesday
|
Print Edition
Print Edition
VALEANT Pharmaceuticals International said yesterday it has agreed to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for US$8.7 billion in cash.
The deal is expected to transform Quebec-based Valeant into a global leader in eye health by strengthening its capabilities in ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.
The deal, to be financed through debt and equity, will see some US$4.5 billion go to an investor group led by Warburg Pincus LLC, with some US$4.2 billion used to pay down Bausch & Lomb's outstanding debt.
The deal is expected to transform Quebec-based Valeant into a global leader in eye health by strengthening its capabilities in ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.
The deal, to be financed through debt and equity, will see some US$4.5 billion go to an investor group led by Warburg Pincus LLC, with some US$4.2 billion used to pay down Bausch & Lomb's outstanding debt.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
